Administration de facteur VII activé recombinant chez une patiente porteuse d'une assistance mécanique ventriculaire gauche [rFVIIa administration in patient with a left ventricular assistance patient]

Détails

ID Serval
serval:BIB_AFE8864CC685
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Administration de facteur VII activé recombinant chez une patiente porteuse d'une assistance mécanique ventriculaire gauche [rFVIIa administration in patient with a left ventricular assistance patient]
Périodique
Annales francaises d'anesthesie et de reanimation
Auteur⸱e⸱s
Tual L., Kirsch M., Servant J.M., Drouet L., Dhonneur G.
ISSN
0750-7658 (Print)
ISSN-L
0750-7658
Statut éditorial
Publié
Date de publication
01/2006
Peer-reviewed
Oui
Volume
25
Numéro
1
Pages
29-32
Langue
français
Notes
Publication types: Case Reports ; English Abstract ; Journal Article
Publication Status: ppublish
Résumé
We report the case of a left ventricular mechanical assistance (Incor Berlinheart) in a woman that experienced a postoperative non-surgical haemorrhagic complication following a reconstructive pedicled omentoplasty for implanted materials infection. After massive substitutive therapy failure at reducing blood loss and because of an hypovolaemic shock, high dosage (70 microg/kg twice) of recombinant activated factor VII (r-VIIa) was administrated resulting in spectacular cessation of bleeding and haemodynamic restoration. Continuous repeated clinical evaluation, cardiac echography and electronic monitoring of the axial pump device characteristic did not reveal any thromboembolic accident. This observation brings some indirect arguments for safe rFVIIa treatment in this type of pathology with a high thromboembolic risk.
Mots-clé
Aged, Factor VIIa/therapeutic use, Heart-Assist Devices, Hemorrhage/drug therapy, Humans, Male, Omentum/surgery, Postoperative Complications/drug therapy, Prosthesis-Related Infections/surgery, Recombinant Proteins/therapeutic use, Shock/drug therapy, Thromboembolism/complications
Pubmed
Web of science
Création de la notice
30/03/2019 17:48
Dernière modification de la notice
20/08/2019 16:19
Données d'usage